Cite
van der Linden M, Meeuwis K, van Hees C, et al. The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR Res Protoc. 2017;6(9):e178doi: 10.2196/resprot.7503.
van der Linden, M., Meeuwis, K., van Hees, C., van Dorst, E., Bulten, J., Bosse, T., IntHout, J., Boll, D., Slangen, B., van Seters, M., van Beurden, M., van Poelgeest, M., & de Hullu, J. (2017). The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR research protocols, 6(9), e178. https://doi.org/10.2196/resprot.7503
van der Linden, Michelle, et al. "The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease." JMIR research protocols vol. 6,9 (2017): e178. doi: https://doi.org/10.2196/resprot.7503
van der Linden M, Meeuwis K, van Hees C, van Dorst E, Bulten J, Bosse T, IntHout J, Boll D, Slangen B, van Seters M, van Beurden M, van Poelgeest M, de Hullu J. The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease. JMIR Res Protoc. 2017 Sep 06;6(9):e178. doi: 10.2196/resprot.7503. PMID: 28877863; PMCID: PMC5607434.
Copy
Download .nbib